Description
A dual inhibitor of CK2 and ERK8 (IC50 = 0.5 µM for both); binds to Pim-1, HIPK2, and DYRK1A (Kis = 8.65, 15.25, and 11.9 µM, respectively) and inhibits greater than 50% of the activity of five kinases, including CK2, ERK8, and DYRK2, in a panel of 78 kinases at 10 µM; induces apoptosis in Jurkat cells at 10-50 µM
Formal name: 4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzimidazole-1-acetic acid
Synonyms:
Molecular weight: 534.8
CAS: 1085822-09-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|CK2||Product Type|Biochemicals|Kinase Inhibitors|RAS/RAF/MEK/ERK/MAPK||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Cell Signaling|ERK/MAPK Signaling